While the vast majority of biomarker discovery to date has focused on genomics, >80% of disease risk stems from non-genetic factors and exposures over time. This molecular landscape has remained largely unexplored, until now.
Sapient’s innovative technologies finally enable rapid, large-scale profiling of metabolite, lipid, and protein biomarkers, which read out dynamic factors influencing health and disease – measuring thousands of biomarkers per sample, across thousands of samples at a time.
Supported by an advanced biocomputational framework for analysis of multi-omics datasets, we deliver data insights to elucidate disease mechanisms, subtype diseases, and ultimately improve the precision and efficacy of therapies.
Identify differentially expressed, disease-modifying, and tractable therapeutic targets that can be acted upon by your drug.
Confirm a target’s role in disease process and/or the effects of pharmacological modulation of the target.
